PHAT - Phathom Pharmaceuticals, Inc.

Dashboard

Manage Tickers Link Financial Account

PHATPhathom Pharmaceuticals, Inc.

Nasdaq phathompharma.com

$ 10.12 $ -0.01 (-0.1 %)

Thursday, 09-May-2024 15:59:53 EDT

CLICK TO SEE RELEVANT LITIGATION UPDATES

Y-mAbs Therapeutics, Inc. | YMAB | Take Action!

QQQ $ 441.33 $ 0.96 (0.22 %)

DIA $ 394.43 $ 3.52 (0.9 %)

SPY $ 520.56 $ 2.98 (0.58 %)

TLT $ 90.69 $ 0.44 (0.49 %)

GLD $ 216.93 $ 3.37 (1.58 %)

Previous Close

$ 10.09

Open

$ 10.07

Bid

$ 10.09 x 700

Ask

$ 0.00 x 0

Day's Range

$ 9.99 - $ 11.01

52 Week Range

$ 6.07 - $ 17.02

Volume

1,113,580

Average Volume

na

Market Cap

517.51M

Beta (5Y Monthly)

$ 1.04

PE Ratio (TTM)

nm

EPS (TTM)

TBD

Earnings Date

na

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

na

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
1	05-09-2024	03-31-2024	10-Q
2	03-07-2024	12-31-2023	10-K
3	11-09-2023	09-30-2023	10-Q
4	08-10-2023	06-30-2023	10-Q
5	05-10-2023	03-31-2023	10-Q
6	02-28-2023	12-31-2022	10-K
7	11-08-2022	09-30-2022	10-Q
8	08-02-2022	06-30-2022	10-Q
9	05-10-2022	03-31-2022	10-Q
10	03-01-2022	12-31-2021	10-K
11	11-08-2021	09-30-2021	10-Q
12	08-10-2021	06-30-2021	10-Q
13	05-11-2021	03-31-2021	10-Q
14	03-30-2021	12-31-2020	10-K
15	11-10-2020	09-30-2020	10-Q
16	08-06-2020	06-30-2020	10-Q
17	05-12-2020	03-31-2020	10-Q
18	03-19-2020	12-31-2019	10-K
19	11-25-2019	09-30-2019	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Needham Reiterates Buy on Phathom Pharmace...
05/09/2024 17:52:41

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Phathom Pharmaceuticals Says It Will Have ...
05/09/2024 12:03:02

Phathom Pharmaceuticals Q1 2024 GAAP EPS $...
05/09/2024 12:01:57

Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly losses of $(1.42) per share which missed the analyst consensus estimat...

Needham Reiterates Buy on Phathom Pharmace...
05/08/2024 10:03:42

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
05/03/2024 20:09:18

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Stifel Initiates Coverage On Phathom Pharm...
05/03/2024 09:46:10

Stifel analyst Annabel Samimy initiates coverage on Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy rating and announces Pr...

Needham Reiterates Buy on Phathom Pharmace...
04/26/2024 15:16:46

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
04/19/2024 18:42:01

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
04/12/2024 14:09:27

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
04/11/2024 10:27:59

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
04/05/2024 13:43:30

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
04/01/2024 11:01:32

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
03/22/2024 18:14:15

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Maintains Buy on Phathom Pharmaceu...
03/15/2024 14:34:25

Needham analyst Joseph Stringer maintains Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Needham Reiterates Buy on Phathom Pharmace...
03/08/2024 19:22:19

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

HC Wainwright & Co. Reiterates Buy on Phat...
03/08/2024 14:44:33

HC Wainwright & Co. analyst Matthew Caufield reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $...

Needham Reiterates Buy on Phathom Pharmace...
03/07/2024 17:21:22

Needham analyst Joseph Stringer reiterates Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Phathom Pharmaceuticals, As Of December 31...
03/07/2024 13:06:07

Phathom Pharmaceuticals Q4 GAAP EPS $(1.39...
03/07/2024 13:03:37

Phathom Pharmaceuticals (NASDAQ:PHAT) reported quarterly losses of $(1.39) per share which missed the analyst consensus estimat...

earnings-scheduled-for-march-7-2024

Earnings Scheduled For March 7, 2024
03/07/2024 09:49:44

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION